Annika Berntsen
Overview
Explore the profile of Annika Berntsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trepiakas R, Berntsen A, Hadrup S, Bjorn J, Geertsen P, Straten P, et al.
Cytotherapy
. 2010 May;
12(6):721-34.
PMID: 20429791
Background And Aim: Dendritic cells are regarded as the most effective antigen presenting cells and coordinators of the immune response and therefore suitable as vaccine basis. Here we present results...
2.
Berntsen A, Brimnes M, Straten P, Marie Svane I
J Immunother
. 2010 Apr;
33(4):425-34.
PMID: 20386464
Regulatory T cells (Treg) play an important role in the maintenance of immune tolerance and may be one of the obstacles of successful tumor immunotherapy. In this study, we analyzed...
3.
Berntsen A, Trepiakas R, Wenandy L, Geertsen P, Straten P, Andersen M, et al.
J Immunother
. 2008 Sep;
31(8):771-80.
PMID: 18779742
Therapeutic dendritic cell (DC) vaccination against cancer is a strategy aimed at activating the immune system to recognize and destroy tumor cells. In this nonrandomized phase 1/2 trial, we investigated...
4.
Trepiakas R, Pedersen A, Met O, Hansen M, Berntsen A, Marie Svane I
Vaccine
. 2008 May;
26(23):2824-32.
PMID: 18450338
The current "gold standard" for generation of dendritic cell (DC) used in DC-based cancer vaccine studies is maturation of monocyte-derived DCs with tumor necrosis factor-alpha (TNF-alpha)/IL-1beta/IL-6 and prostaglandin E(2) (PGE(2))....
5.
Thorn M, Wang M, Kloverpris H, Schmidt E, Fomsgaard A, Wenandy L, et al.
Cancer Immunol Immunother
. 2007 Apr;
56(11):1755-63.
PMID: 17464507
By the use of a neural network capable of performing quantitative predictions of peptides binding to HLA-A*0201 molecules, we identified a number of nonamer peptides derived from the catalytic subunit...
6.
Berntsen A, Geertsen P, Marie Svane I
Eur Urol
. 2006 May;
50(1):34-43.
PMID: 16675096
Objective: Dendritic cell (DC) vaccination against cancer is a new specific immunotherapeutic approach given with either therapeutic or adjuvant intent. We provide a review of DC vaccination as a treatment...
7.
Marie Svane I, Berntsen A, Trepiakas R, Pedersen A
Ugeskr Laeger
. 2006 Apr;
168(14):1415-20.
PMID: 16584668
Dendritic cell (DC)-based vaccination against cancer is a specific immunotherapy with a new therapeutic approach for patients with cancer. Preclinical and clinical trials, in which more than 1,000 cancer patients...
8.
Fischer C, Perstrup L, Berntsen A, Eskildsen P, Pedersen B
Clin Immunol
. 2005 Aug;
117(2):152-60.
PMID: 16112617
Elevated plasma IL-18 is present in several conditions sharing insulin-resistance as common trait, but the association with insulin-resistance per se is not established. Plasma/serum IL-6, IL-18, TNF-alpha, soluble TNF receptor...
9.
Berntsen A, Bytzer P
Ugeskr Laeger
. 2004 Oct;
166(38):3294-7.
PMID: 15496005
No abstract available.